UKHSA launches call for evidence to tackle rising TB cases

The UK Health Security Agency (UKHSA) has launched a call for evidence to help shape the next five-year Tuberculosis (TB) National Action Plan for England, which will run from 2026 to 2031, as infection rates continue to rise and its epidemiology is changing.

© National Institute of Allergy and Infectious Diseases/Unsplash

© National Institute of Allergy and Infectious Diseases/Unsplash

In 2023, England recorded its largest annual increase (11%) in TB cases since enhanced surveillance began in 2000. Provisional figures for 2024 indicate a further 13% rise in TB cases compared to 2023, reflecting global patterns, with many countries experiencing setbacks in TB control efforts in recent years.

The new Tuberculosis National Action Plan (2026–2031) aims to improve the prevention, detection, and control of TB in England by prioritising the most effective interventions, focusing on those most affected, and addressing health inequalities.

The call for evidence seeks insights from academics, health and social care professionals, public health experts, epidemiologists, data and surveillance scientists, civil society representatives, policymakers, politicians and those with lived experience of tuberculosis.

Dr Esther Robinson, head of theTBUnit atUKHSA, said: While England is still considered a low-incidence country for TB, the rise in cases over recent years means that we are now just below that threshold.

'This call for evidence will help us develop an action plan that prioritises the most effective interventions to reverse this trend, focusing particularly on the needs of those most affected.'

Evidence can be contributed via GOV.UK and the Call for Evidence will close on 2 May 2025. 

Pharma company recalls antidepressant medication

Pharma company recalls antidepressant medication

By Lee Peart 29 April 2026

Pharma company Amarox Limited is recalling one batch of Sertraline 100mg film-coated tablets as a precautionary measure due to a manufacturing error that led...

Inefficiencies cost NHS £1bn in lost productivity, report finds

By Lee Peart 28 April 2026

Routine inefficiencies cost the NHS £1bn in lost productivity and 35m staff hours each year, according to a new report.

Blood pressure medication recall announced by MHRA

By Lee Peart 21 April 2026

Pharmacy and healthcare professionals have been advised to stop supplying a batch of blood pressures medication due to a manufacturing error.


Popular articles by Liz Wells